Only then can pharmaceutical manufacturers pinpoint potential compliance risks and bottlenecks ... against chikungunya approved for use in the US, after Bavarian Nordic gets the green light ...
Simultaneously, Virpax Pharmaceuticals was granted an extension by the Nasdaq Hearings Panel to maintain its listing status, with a compliance deadline set for April 1, 2025. The company also made ...
U.S. FDA classifies Aurobindo Pharma warehouse in New Jersey as Official Action Indicated, impacting compliance and ...
In the backdrop of the US-India dialogue on tariffs, the Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian ...
Subsequently, the US FDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated (OAI)'.
Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering.